FDA OKs Esketamine Nasal Spray Monotherapy for Depression ...Middle East

Medscape - News
FDA OKs Esketamine Nasal Spray Monotherapy for Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded to at least two oral antidepressants. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Esketamine Nasal Spray Monotherapy for Depression )

Also on site :